Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group study. 1978

M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla

Piperazinedione was administered in doses of 9 or 12 mg/m2 by iv infusion every 3 weeks in 28 patients with previously treated malignant melanoma. Of the 25 evaluable patients, 72% had drug-induced toxicity: 40% had leukopenia, 56% had thrombocytopenia, 40% had anemia, and 16% had nausea and vomiting. None of these patients had partial remission, two had stable disease, and the remaining 23 had definite progression of their disease in spite of adequate trial with this agent.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
April 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
February 1991, Investigational new drugs,
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
January 1993, Investigational new drugs,
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
September 1991, Journal of the National Cancer Institute,
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
October 1987, Cancer treatment reports,
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
December 1982, Seminars in oncology,
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
January 1995, Investigational new drugs,
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
January 1995, Investigational new drugs,
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
November 1998, Journal of immunotherapy (Hagerstown, Md. : 1997),
M Al-Sarraf, and T Thigpen, and C W Groppe, and A Haut, and F Padilla
October 1985, American journal of clinical oncology,
Copied contents to your clipboard!